Literature DB >> 33428122

Relationship between TSHR, BRAF and PIK3CA gene copy number variations and thyroid nodules.

Xiaoli Shi1,2, Mengying Qu1, Xing Jin1,3, Lixiang Liu1, Fangang Meng1, Hongmei Shen4.   

Abstract

PURPOSE: This study aims to investigate the relationship between the TSHR, BRAF, and PIK3CA gene copy number variations (CNVs) and thyroid nodules by analyzing gene CNVs, and to explore the interaction between iodine status and the above genes CNVs in the occurrence of thyroid nodules.
METHODS: Three hundred and ninety-five subjects were selected from 3 regions with different iodine status in Shanxi Province of China, including 192 patients with thyroid nodules and 203 healthy controls. The basic information about subjects had been obtained through a questionnaire. B ultrasound was utilized to check thyroid nodules. Blood and urine samples were harvested to detect the thyroid function and urinary iodine concentration. Real-time quantitative polymerase chains reaction (RT-PCR) served to detect CNVs in DNA from human blood.
RESULTS: There was an association between TSHR gene CNV and thyroid nodules (χ2 = 8.403, P = 0.004). The prevalence of BRAF and PIK3CA gene CNVs was not statistically significant between the case group and the control group. Differences in the TSHR gene CNV rates for cases of the 3 areas were statistically significant (χ2 = 10.072, P = 0.007). No statistical difference in the prevalence rates of the 3 genes CNVs between diverse characteristics of thyroid nodules was observed. UIC > 300 μg/L (OR = 1.74, 95% CI: 1.02-2.96, P = 0.041) and TSHR gene CNV (OR = 3.53, 95% CI: 1.40-8.92, P = 0.008) were risk factors for thyroid nodules. There was no significant interaction between the UIC and the examined genes CNVs.
CONCLUSIONS: TSHR gene CNV and high urinary iodine levels can increase the risk of thyroid nodules. But the interactions between the 3 above genes CNVs and iodine nutrition were not found in the occurrence of thyroid nodules.

Entities:  

Keywords:  BRAF; Copy number variation; PIK3CA; TSHR; Thyroid nodules; Urinary iodine

Mesh:

Substances:

Year:  2021        PMID: 33428122     DOI: 10.1007/s12020-020-02587-9

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  26 in total

Review 1.  Implications of gene copy-number variation in health and diseases.

Authors:  Suhani H Almal; Harish Padh
Journal:  J Hum Genet       Date:  2011-09-29       Impact factor: 3.172

Review 2.  Thyroid nodules.

Authors:  Geanina Popoveniuc; Jacqueline Jonklaas
Journal:  Med Clin North Am       Date:  2012-03       Impact factor: 5.456

Review 3.  Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

4.  Searching for the most effective thyrotropin (TSH) threshold to rule-out autonomously functioning thyroid nodules in iodine deficient regions.

Authors:  Luca Giovanella; Federica D'Aurizio; Alfredo Campenni'; Rosaria Maddalena Ruggeri; Sergio Baldari; Frederik Anton Verburg; Pierpaolo Trimboli; Luca Ceriani
Journal:  Endocrine       Date:  2016-09-15       Impact factor: 3.633

5.  Prevalence of Thyroid Nodules and Its Relationship with Iodine Status in Shanghai: a Population-based Study.

Authors:  Jun Song; Shu Rong Zou; Chang Yi Guo; Jia Jie Zang; Zhen Ni Zhu; Ming Mi; Cui Hua Huang; Hui Ting Yu; Xi Lu; Ye Ruan; Fan Wu
Journal:  Biomed Environ Sci       Date:  2016-06       Impact factor: 3.118

6.  Cancer risk and clinicopathological characteristics of thyroid nodules harboring thyroid-stimulating hormone receptor gene mutations.

Authors:  Sann Y Mon; Gregory Riedlinger; Collette E Abbott; Raja Seethala; N Paul Ohori; Marina N Nikiforova; Yuri E Nikiforov; Steven P Hodak
Journal:  Diagn Cytopathol       Date:  2018-03-08       Impact factor: 1.582

Review 7.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

Review 8.  Molecular genetics and diagnosis of thyroid cancer.

Authors:  Yuri E Nikiforov; Marina N Nikiforova
Journal:  Nat Rev Endocrinol       Date:  2011-08-30       Impact factor: 43.330

9.  Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population.

Authors:  Jehad Abubaker; Zeenath Jehan; Prashant Bavi; Mehar Sultana; Sayer Al-Harbi; Muna Ibrahim; Abdulrahman Al-Nuaim; Mohammed Ahmed; Tarek Amin; Maha Al-Fehaily; Osama Al-Sanea; Fouad Al-Dayel; Shahab Uddin; Khawla S Al-Kuraya
Journal:  J Clin Endocrinol Metab       Date:  2007-11-13       Impact factor: 5.958

Review 10.  Thyroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies.

Authors:  Luciana Reck Remonti; Caroline Kaercher Kramer; Cristiane Bauermann Leitão; Lana Catani F Pinto; Jorge Luiz Gross
Journal:  Thyroid       Date:  2015-03-31       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.